These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9769950)

  • 1. TP53 and hepatocellular carcinoma.
    Puisieux A; Ozturk M
    Pathol Biol (Paris); 1997 Dec; 45(10):864-70. PubMed ID: 9769950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese.
    Ng IO; Chung LP; Tsang SW; Lam CL; Lai EC; Fan ST; Ng M
    Oncogene; 1994 Mar; 9(3):985-90. PubMed ID: 8108145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
    Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
    Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
    Hosono S; Chou MJ; Lee CS; Shih C
    Oncogene; 1993 Feb; 8(2):491-6. PubMed ID: 8093978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
    Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells.
    Petitjean A; Cavard C; Shi H; Tribollet V; Hainaut P; Caron de Fromentel C
    Oncogene; 2005 Jan; 24(3):512-9. PubMed ID: 15543231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational hotspot in the p53 gene in human hepatocellular carcinomas.
    Hsu IC; Metcalf RA; Sun T; Welsh JA; Wang NJ; Harris CC
    Nature; 1991 Apr; 350(6317):427-8. PubMed ID: 1849234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines.
    Hosono S; Lee CS; Chou MJ; Yang CS; Shih CH
    Oncogene; 1991 Feb; 6(2):237-43. PubMed ID: 1847999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein.
    Gouas DA; Shi H; Hautefeuille AH; Ortiz-Cuaran SL; Legros PC; Szymanska KJ; Galy O; Egevad LA; Abedi-Ardekani B; Wiman KG; Hantz O; Caron de Fromentel C; Chemin IA; Hainaut PL
    Carcinogenesis; 2010 Aug; 31(8):1475-82. PubMed ID: 20538734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of TP53 codon 249 mutations in young Guinean children with high aflatoxin exposure.
    Turner PC; Sylla A; Kuang SY; Marchant CL; Diallo MS; Hall AJ; Groopman JD; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2053-5. PubMed ID: 16103461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TP53 and liver carcinogenesis.
    Staib F; Hussain SP; Hofseth LJ; Wang XW; Harris CC
    Hum Mutat; 2003 Mar; 21(3):201-16. PubMed ID: 12619106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of p53 gene in hepatocellular carcinoma in Taiwan.
    Sheu JC; Huang GT; Lee PH; Chung JC; Chou HC; Lai MY; Wang JT; Lee HS; Shih LN; Yang PM
    Cancer Res; 1992 Nov; 52(21):6098-100. PubMed ID: 1327523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 as a growth suppressor gene in HBV-related hepatocellular carcinoma cells.
    Puisieux A; Ponchel F; Ozturk M
    Oncogene; 1993 Feb; 8(2):487-90. PubMed ID: 8381223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target gene modulation in hepatocellular carcinomas by decreased DNA-binding of p53 mutations.
    Kubicka S; Trautwein C; Niehof M; Manns M
    Hepatology; 1997 Apr; 25(4):867-73. PubMed ID: 9096590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
    Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
    Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma].
    Qin L; Tang Z; Liu K
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):405-8. PubMed ID: 8697987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of high frequency 249 codon mutation of p53 gene in hepatocellular carcinoma in prevalent area of China].
    Ming L; Yuan B; Thorgeirsson SS
    Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):122-4. PubMed ID: 11776852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 gene in hepatocellular carcinomas from Australia.
    Vesey DA; Hayward NK; Cooksley WG
    Cancer Detect Prev; 1994; 18(2):123-30. PubMed ID: 8025894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
    Kirk GD; Lesi OA; Mendy M; Szymañska K; Whittle H; Goedert JJ; Hainaut P; Montesano R
    Oncogene; 2005 Sep; 24(38):5858-67. PubMed ID: 16007211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
    Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ
    Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.